Updated on 26 June 2013
Ms Sabrina S K Chan, executive director, Hong Kong Association of the Pharmaceutical Industry (HKAPI)
Founded in 1968, the Hong Kong Association of the Pharmaceutical Industry (HKAPI) has 71 members, which includes the 20 top global pharmaceutical companies. HKAPI's member companies supply over 70 percent of the prescription medicines in Hong Kong.
The association's mission is to enhance the public health of Hong Kong citizens by making innovative new drug therapies available. To accomplish this, the association makes recommendations to public health policy makers on behalf of its members.
Ms Sabrina S K Chan, executive director, Hong Kong Association of the Pharmaceutical Industry (HKAPI), Hong Kong, shares her thoughts on current challenges faced by pharmaceutical companies in Hong Kong and the changes required in regulatory approval process. Here are the excerpts:
What is the total number of members of your association? What is the eligibility to become a member of your association?
We have a total of 71 members, among which 39 are full members, 30 are associate members and two are affiliate members. In order to obtain a full membership, which is given to companies engaged in R&D of pharmaceuticals, a company should also manufacture in accordance with good manufacturing practice and quality control protocols. Companies whose business is primarily the manufacture of generic products are excluded from membership. On the other hand, companies, which qualify as full members but do not yet have a product in the Hong Kong market, are given affiliate membership. Associate membership is extended to companies engaged in providing services to the pharmaceutical industry.
What is the size of pharmaceutical industry of Hong Kong?
The Hong Kong pharmaceutical market is around $7 billion (HK$ 55billion) and the country is trying to focus more on this industry. It is making efforts to get expertise in regulatory approval and is looking at adopting new initiatives and policy. Hong Kong has a highly ageing population and the demand of healthcare is also substantial. Therefore, the objective of the association is to expedite regulatory environment in the country.
What is the role of HKAPI when it comes regulatory norms in Hong Kong?
We have 30 associate members companies along with 38 R&D based multinational companies as our members. These firms provide services to our full members, including the Hong Kong Science Park and law firm.